Roswell Park Comprehensive Cancer center
Buffalo, New York 14263-0001
48 studies enrolling now · 158 studies all time
What they study most
ALK-Positive Large B-Cell Lymphoma, AML, AML With Mutated NPM1, AML, Adult, ANCA-Associated Vasculitis (AAV), Abdominal Neoplasm, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Pediatric, Acute Myelogenous Leukemia, Acute Myeloid Leukemia
Studies at this site
- A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
- A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — Recruiting now
- A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Recruiting now
- A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) — Recruiting now
- A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma — Recruiting now
- Intratumoral N17350 in Advanced Solid Tumors — Recruiting now
- AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma — Recruiting now
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes — Recruiting now
- A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer — Recruiting now
- First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
- A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) — Recruiting now
- GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer — Recruiting now
- (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — Recruiting now
- GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC — Recruiting now
- CapTemY90 for Grade 2/3 NET Liver Metastases — Recruiting now
- Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas — Recruiting now
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma — Recruiting now
- International Registry for Men With Advanced Prostate Cancer (IRONMAN) — Recruiting now
- Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing — Recruiting now
- A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer — Recruiting now
- SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers — Recruiting now
- Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study) — Recruiting now
- Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. — Recruiting now
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) — Recruiting now
- Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3 — Recruiting now
- SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Recruiting now
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
- Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study — Recruiting now
- Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — Recruiting now
- A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes — Recruiting now
- Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC — Recruiting now
- A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML) — Recruiting now
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
- Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors — Recruiting now
- A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML — Recruiting now
- A Patient Navigation Program for Addressing Disparities in Breast Cancer Care — Recruiting now
- Study of SGR-1505 in Mature B-Cell Neoplasms — Recruiting now
- Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial — Recruiting now
- A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue — Recruiting now
- A Phase 1 Study of LNCB74 in Advanced Solid Tumors — Recruiting now
- Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients — Recruiting now
- A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer — Recruiting now
- ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML — Recruiting now
- Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients — Recruiting now
- Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) — Recruiting now
- Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. — Recruiting now
- Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome — Running, not enrolling
- Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms — Starting soon
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma — Running, not enrolling